Skip to main content
Premium Trial:

Request an Annual Quote

Genome BC Invests C$750K in Startup Microbiome Insights

NEW YORK (GenomeWeb) – Genome BC said today that it is investing C$750,000 ($586,000) in Microbiome Insights (MBI), a Vancouver-based microbiome testing company.

MBI provides next-generation sequencing-based analytical testing and consulting services to microbiome researchers in academia and industry.

The new funding, combined with a recently closed equity financing round for an undisclosed amount, will be used to accelerate the company's sales and marketing activities, make new hires, build a new CLIA-certified lab facility, and develop and launch new services and personal health test products.

"The explosive growth in microbiome research — given its fundamental importance to human, animal, plant, and environmental health — has significantly outpaced existing capacity to provide microbiome testing, especially outside of academia. The building of this new industry is a unique market opportunity," MBI CEO Malcolm Kendall said in a statement.

Genome BC made the investment in MBI through its Industry Innovation, or I2 Fund, which provides commercialization support for companies developing life science technologies that address biological challenges in key economic sectors in BC including agriculture, energy and mining, environment, fisheries and aquaculture, forestry, and human health.

The Scan

Not Yet a Permanent One

NPR says the lack of a permanent Food and Drug Administration commissioner has "flummoxed" public health officials.

Unfair Targeting

Technology Review writes that a new report says the US has been unfairly targeting Chinese and Chinese-American individuals in economic espionage cases.

Limited Rapid Testing

The New York Times wonders why rapid tests for COVID-19 are not widely available in the US.

Genome Research Papers on IPAFinder, Structural Variant Expression Effects, Single-Cell RNA-Seq Markers

In Genome Research this week: IPAFinder method to detect intronic polyadenylation, influence of structural variants on gene expression, and more.